Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07452081
Recruiting Not applicable

Combined Effect of Sensory-motor Integration in Individuals With Postmenopausal Polyneuropathy

NCT07452081 · tracked via the Priya Life Science Egypt tracker
Sponsor
New Ismailia National University
Phase
Not applicable
Started
2026-02-01
Last updated
2026-03-05

Condition(s) studied

Sensory-Motor Axonal Neuropathy

Investigational drug(s) / intervention(s)

sensory motor integrationtraditional excercises

sensory motor integration: pelvic rocking training and strengthening exercises

traditional excercises: conventional

Study summary

Detect the combined effect of sensory-motor integration in individuals with postmenopausal polyneuropathy

Eligibility

Sex
FEMALE
Min age
45 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * polyneuropathy pos-tmaneuposal * Type II Diabetes Mellitus * Suffering from numbness in upper and lower limbs for more than 4 months Exclusion Criteria: * hysterectomy * tumors * antidepressant dugs

Primary outcome measure(s)

  • pain intensity — 6 weeks
    pain management will be evaluated by visual analogue scale with a minimum score of zero, and the maximum score is ten in addition, zero means a better score
  • balance assessment — 6 weeks
    changes in balance parameters will be evaluated by the Biodex balance system that calculate the mediolateral stability index, anteroposterior stability index, and the overall. stability index.These indexes represent fluctuations around a zero point established before testing when the platform is stable. A high oSi score indicates poor balance, and the patient's maximum overall score would be 1.60.

Trial sites (2)

FacilityCityRegionStatus
Mohamed Ismailia Egypt Recruiting
Zaytona University in Jordon Amman Jordan Recruiting

More New Ismailia National University trials in Egypt

Impact of Virtual Reality on Painful Menstruation Recruiting
Evaluation of Exercise Capacity in Teenage Females Using Virtual Reality and Plyometric Workout Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07452081 on ClinicalTrials.gov ↗ ← All trials in Egypt